Boiron SA (BON)
XHAN
Real-time Data
06:00 AM
Day's Range
25.5052 wk Range
20.65Overview - BON - Boiron SA
Key Statistics
Valuation
Enterprise Value
-47.85M
P/E (Trailing)
‪13.56‬
EV / EBITDA
‪-0.92‬
Profitability
Profit Margin
‪72.98%‬
Operating Margin
‪8.77%‬
Return on Assets
‪5.41%‬
Return on Equity
‪8.31%‬
Ownership
Shares Outstanding
17.36M
Price stats
50-Day Avg
‪26.65‬
200-Day Avg
‪27.28‬
Dividends
Frequency
Annual
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - BON - Boiron SA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XHAN.
- BONXHANBoiron SA+15.23%52-week change13.62P/E (Trailing)‪72.98%‬Profit Margin
- PBFXHANPictet-Biotech-P USD+40.76%52-week change—P/E (Trailing)—Profit Margin
- LDZAXHANAspen Pharmacare Holdings Limited+32.67%52-week change-3.08P/E (Trailing)‪44.11%‬Profit Margin
- ANLXHANAnalog Devices, Inc.+32.46%52-week change69.63P/E (Trailing)‪61.46%‬Profit Margin
- PARXHANParker-Hannifin Corporation+24.61%52-week change31.04P/E (Trailing)‪36.85%‬Profit Margin
- MRKXHANMerck KGaA+19.14%52-week change22.95P/E (Trailing)‪58.50%‬Profit Margin
- DMPXHANDermapharm Holding SE+15.62%52-week change16.14P/E (Trailing)‪67.20%‬Profit Margin
Profile Summary - BON - Boiron SA
About
Boiron SA is a leading pharmaceutical company specializing in the production and distribution of homeopathic medicines, recognized as the world's largest manufacturer in this field. Founded in 1932 by twin brothers Jean and Henri Boiron, pharmacists with expertise in science and microbiology, it originated as the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
